US Stock MarketDetailed Quotes

MDGL Madrigal Pharmaceuticals

Watchlist
  • 287.240
  • 0.0000.00%
Close Jul 19 16:00 ET
  • 287.240
  • 0.0000.00%
Pre 08:00 ET
6.12BMarket Cap-12413P/E (TTM)

Madrigal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
94.08%152.04M
29.61%380.5M
37.37%117.18M
22.54%98.53M
23.02%86.45M
36.03%78.34M
21.07%293.57M
32.04%85.3M
27.31%80.41M
13.82%70.27M
Selling and administrative expenses
399.32%80.8M
124.70%108.15M
219.68%46.54M
127.19%27.58M
51.56%17.85M
67.55%16.18M
28.97%48.13M
24.29%14.56M
46.51%12.14M
16.46%11.77M
-General and administrative expense
----
124.70%108.15M
219.68%46.54M
127.19%27.58M
51.56%17.85M
----
28.97%48.13M
24.29%14.56M
46.51%12.14M
16.46%11.77M
Research and development costs
14.61%71.24M
10.96%272.35M
-0.14%70.64M
3.93%70.95M
17.28%68.61M
29.68%62.15M
19.63%245.44M
33.76%70.74M
24.42%68.27M
13.30%58.5M
Operating profit
-94.08%-152.04M
-29.61%-380.5M
-37.37%-117.18M
-22.54%-98.53M
-23.02%-86.45M
-36.03%-78.34M
-21.07%-293.57M
-32.04%-85.3M
-27.31%-80.41M
-13.82%-70.27M
Net non-operating interest income expense
212.22%4.5M
485.95%6.87M
922.11%4.98M
73.76%-206K
242.23%650K
1,986.96%1.44M
-590.08%-1.78M
-1,265.38%-606K
-1,408.33%-785K
-602.20%-457K
Non-operating interest income
120.71%8.33M
796.02%19.58M
732.06%8.95M
359.97%3.3M
999.38%3.55M
5,372.46%3.78M
501.93%2.19M
1,969.23%1.08M
1,095.00%717K
254.95%323K
Non-operating interest expense
64.30%3.84M
220.69%12.71M
136.09%3.97M
133.29%3.5M
271.92%2.9M
--2.34M
--3.96M
--1.68M
--1.5M
--780K
Other net income (expense)
Income before tax
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
-28.68%-81.2M
-14.73%-70.73M
Income tax
Net income
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
-28.68%-81.2M
-14.73%-70.73M
Net income continuous Operations
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
-28.68%-81.2M
-14.73%-70.73M
Minority interest income
Net income attributable to the parent company
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
-28.68%-81.2M
-14.73%-70.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-91.87%-147.54M
-26.50%-373.63M
-30.60%-112.19M
-21.61%-98.74M
-21.31%-85.8M
-33.69%-76.9M
-22.12%-295.35M
-33.08%-85.91M
-28.68%-81.2M
-14.73%-70.73M
Basic earnings per share
-74.47%-7.38
-16.02%-19.99
-14.86%-5.72
-12.42%-5.34
-13.29%-4.69
-25.89%-4.23
-17.77%-17.23
-31.75%-4.98
-25.33%-4.75
-11.29%-4.14
Diluted earnings per share
-74.47%-7.38
-16.02%-19.99
-14.86%-5.72
-12.42%-5.34
-13.29%-4.69
-25.89%-4.23
-17.77%-17.23
-31.75%-4.98
-25.33%-4.75
-11.29%-4.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 94.08%152.04M29.61%380.5M37.37%117.18M22.54%98.53M23.02%86.45M36.03%78.34M21.07%293.57M32.04%85.3M27.31%80.41M13.82%70.27M
Selling and administrative expenses 399.32%80.8M124.70%108.15M219.68%46.54M127.19%27.58M51.56%17.85M67.55%16.18M28.97%48.13M24.29%14.56M46.51%12.14M16.46%11.77M
-General and administrative expense ----124.70%108.15M219.68%46.54M127.19%27.58M51.56%17.85M----28.97%48.13M24.29%14.56M46.51%12.14M16.46%11.77M
Research and development costs 14.61%71.24M10.96%272.35M-0.14%70.64M3.93%70.95M17.28%68.61M29.68%62.15M19.63%245.44M33.76%70.74M24.42%68.27M13.30%58.5M
Operating profit -94.08%-152.04M-29.61%-380.5M-37.37%-117.18M-22.54%-98.53M-23.02%-86.45M-36.03%-78.34M-21.07%-293.57M-32.04%-85.3M-27.31%-80.41M-13.82%-70.27M
Net non-operating interest income expense 212.22%4.5M485.95%6.87M922.11%4.98M73.76%-206K242.23%650K1,986.96%1.44M-590.08%-1.78M-1,265.38%-606K-1,408.33%-785K-602.20%-457K
Non-operating interest income 120.71%8.33M796.02%19.58M732.06%8.95M359.97%3.3M999.38%3.55M5,372.46%3.78M501.93%2.19M1,969.23%1.08M1,095.00%717K254.95%323K
Non-operating interest expense 64.30%3.84M220.69%12.71M136.09%3.97M133.29%3.5M271.92%2.9M--2.34M--3.96M--1.68M--1.5M--780K
Other net income (expense)
Income before tax -91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M-28.68%-81.2M-14.73%-70.73M
Income tax
Net income -91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M-28.68%-81.2M-14.73%-70.73M
Net income continuous Operations -91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M-28.68%-81.2M-14.73%-70.73M
Minority interest income
Net income attributable to the parent company -91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M-28.68%-81.2M-14.73%-70.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -91.87%-147.54M-26.50%-373.63M-30.60%-112.19M-21.61%-98.74M-21.31%-85.8M-33.69%-76.9M-22.12%-295.35M-33.08%-85.91M-28.68%-81.2M-14.73%-70.73M
Basic earnings per share -74.47%-7.38-16.02%-19.99-14.86%-5.72-12.42%-5.34-13.29%-4.69-25.89%-4.23-17.77%-17.23-31.75%-4.98-25.33%-4.75-11.29%-4.14
Diluted earnings per share -74.47%-7.38-16.02%-19.99-14.86%-5.72-12.42%-5.34-13.29%-4.69-25.89%-4.23-17.77%-17.23-31.75%-4.98-25.33%-4.75-11.29%-4.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg